1252. A Real-World Observational Study on HIV-Infected Patients who Switched from Nevirapine + 2 Nucleoside Reverse Transcriptase Inhibitors to Dolutegravir/Lamivudine in British Columbia, Canada

BACKGROUND: Although convenient single-tablet antiretroviral regimens have been developed to treat HIV in recent years, some patients have continued to take a multi-tablet treatment, nevirapine extended-release (NVP XR) plus two nucleoside reverse transcriptase inhibitors (NRTIs) due to its excellen...

Descripción completa

Detalles Bibliográficos
Autores principales: de Wet, Joss, Ban, Joann K, Verdier, Gustavo, Ling, JueJing, Eberg, Maria, Bunko, Andrean, McKimm, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752107/
http://dx.doi.org/10.1093/ofid/ofac492.1083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752107/
http://dx.doi.org/10.1093/ofid/ofac492.1083

Ejemplares similares